HIV-protease inhibitors potentiate the activity of carfilzomib in triple-negative breast cancer.
Besse A, Sedlarikova L, Buechler L, Kraus M, Yang CH, Strakova N, Soucek K, Navratil J, Svoboda M, Welm AL, Joerger M, Driessen C, Besse L.
Besse A, et al.
Br J Cancer. 2024 Sep;131(5):918-930. doi: 10.1038/s41416-024-02774-9. Epub 2024 Jul 5.
Br J Cancer. 2024.
PMID: 38969867
Free PMC article.